World's first inactivated Sabin polio vaccine approved by China FDA

China's FDA has awarded marketing approval of the world's first Sabin strain inactivated polio vaccine, marking a milestone as well for the Institute of Medical Biology of the Academy of Medical Sciences.

The institute independently developed the strain but tapped the assistance of the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), Japan's National Institute of Infectious Diseases (NIID), the European Medicines Agency (EMA) and the U.K. in the review process, CFDA said.

China intends to provide the vaccine to developing countries through WHO's polio eradication program.

- here's the announcement from the CFDA (in Chinese)

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.